Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Aug 8, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring new ways to help teens and young adults reduce their vaping habits. With vaping becoming more common among young people, there is a growing concern about its health risks, and many teens may not feel comfortable discussing their vaping with parents or doctors. The trial will use social media to reach out to those who want to quit vaping and will provide support through a mobile app. This app includes a chatbot that helps users find personalized resources and encouragement to stop vaping. The study aims to see how well this approach works in helping participants decrease their vaping behaviors.

To participate in this trial, individuals need to be U.S. residents, speak English, and have daily access to a smartphone. They should currently be using vaping products and express a desire to stop or be experiencing health issues related to vaping. The trial is not yet recruiting, but once it begins, participants can expect to engage with the mobile app and receive tailored support for their vaping cessation journey. This innovative study could pave the way for effective new methods to help young people quit vaping.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • US Resident
• • English Speaking
• • Have daily access to a smartphone
• • Current vaping product user (P30D)
• • Identified as socially networking about a desire to quit vaping and/or experiencing negative health outcomes due to vaping
• • Vaping product user only (i.e., not using vaping as a means to support combustible smoking cessation)